U.S. Markets close in 3 hrs 54 mins
  • S&P 500

    3,429.50
    -6.06 (-0.18%)
     
  • Dow 30

    28,162.58
    -48.24 (-0.17%)
     
  • Nasdaq

    11,426.82
    -57.88 (-0.50%)
     
  • Russell 2000

    1,617.98
    +14.21 (+0.89%)
     
  • Crude Oil

    40.83
    +0.80 (+2.00%)
     
  • Gold

    1,901.30
    -28.20 (-1.46%)
     
  • Silver

    24.63
    -0.61 (-2.42%)
     
  • EUR/USD

    1.1826
    -0.0041 (-0.3430%)
     
  • 10-Yr Bond

    0.8500
    +0.0340 (+4.17%)
     
  • Vix

    28.24
    -0.41 (-1.43%)
     
  • GBP/USD

    1.3088
    -0.0055 (-0.4175%)
     
  • USD/JPY

    104.8740
    +0.3140 (+0.3003%)
     
  • BTC-USD

    12,937.84
    +1,880.83 (+17.01%)
     
  • CMC Crypto 200

    261.12
    +5.02 (+1.96%)
     
  • FTSE 100

    5,785.65
    +9.15 (+0.16%)
     
  • Nikkei 225

    23,474.27
    -92.73 (-0.39%)
     

J&J signs manufacturing deal with GRAM for potential COVID-19 vaccine

·1 min read

Sept 25 (Reuters) - Johnson & Johnson has signed a manufacturing deal for its coronavirus vaccine candidate with Grand River Aseptic Manufacturing Inc, the contract manufacturing organization said on Friday.

Michigan-based GRAM will manufacture the healthcare conglomerate's SARS-CoV-2 vaccine candidate, which is being developed with part funding from the U.S. government, and provide finished vials.

Earlier in the week, J&J launched a late-stage trial of its experimental single-shot COVID-19 vaccine and said its expects results of the trial by year end or early next year.

J&J, which is readying its supply chain to start distribution as soon as it gets FDA's approval, expects to manufacture as many as 1 billion doses in 2021. (Reporting By Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)